Jacou, France

Gilles Baylac

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Solvay (Societe Anonyme). Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Baylac. Retrieved from https://idiyas.com/inventor/gilles-baylac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilles Baylac: Innovator in Biologically Active Tablets

Introduction

Gilles Baylac is a notable inventor based in Jacou, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tablets that incorporate biologically active substances.

Latest Patents

Gilles Baylac holds a patent for "Tablets comprising a biologically active substance and an excipient containing calcium carbonate." This innovative tablet formulation includes at least one biologically active substance and an excipient that contains calcium carbonate, along with various additives such as fatty acids, lipid materials, and polysaccharides. The method for producing these tablets emphasizes the use of calcium carbonate for the prolonged release of the active substance.

Career Highlights

Baylac's career is marked by his work at Solvay, a prominent company in the chemical and pharmaceutical industry. His expertise in formulating tablets has positioned him as a key player in the development of effective drug delivery systems.

Collaborations

Throughout his career, Gilles Baylac has collaborated with talented professionals, including Karine Cavalier and Didier Sy. These partnerships have contributed to the advancement of his innovative projects.

Conclusion

Gilles Baylac's work in the field of biologically active tablets showcases his commitment to innovation and excellence in pharmaceutical development. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…